Cervix uteri cancer: traditional and new approaches to the problem
- Authors: Payanidi Y.G.1, Zhordania K.I.1, Savostikova M.V.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center
- Issue: No 7 (2015)
- Pages: 94-99
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247542
- ID: 247542
Cite item
Open Access
Access granted
Abstract
In the past decades, the number of patients with cervix uteri cancer has increased in geometric progression worldwide. The WHO confirms this and sounds the alarm - this abnormality has recently begun affecting young women of the earliest reproductive age. This information makes the medical community look more intently at this problem and search for new ways of improving treatment. A study of the pathogenetic role of human papillomavirus (HPV) in the occurrence of this disease, early diagnosis, current treatment options, and prevention absolutely yield certain results - five-year survival rates have reached a rather high level. But unfortunately there is a category of patients whom we cannot help. To update a program for population screening and that for vaccination of HPV-infected women are herewith promising areas.
Keywords
Full Text
About the authors
Yulia G. Payanidi
N.N. Blokhin Russian Cancer Research CenterDoctor of Medicine, Ph.D. in Medical Sciences, Gynecologic Oncology
Kirill I. Zhordania
N.N. Blokhin Russian Cancer Research CenterDoctor of Medicine, Ph.D. in Medical Sciences, Gynecologic Oncology
Marina V. Savostikova
N.N. Blokhin Russian Cancer Research Center
References
- Энциклопедический словарь медицинских терминов. М.: Советская энциклопедия; 1984; т.3: 129. [Collegiate dictionary of medical terms. M Soviet Encyclopedia; 1984; V.3: 129. (in Russian)]
- Aksel Е.М. Статистика злокачественных новообразований женской половой сферы. Онкогинекология. 2012; 1: 18-23. [Aksel E.M. Statistics malignant neoplasms of female genitalia. Onkoginekologiya. 2012; 1: 18-23. (in Russian)]
- Короленкова Л.И. Донашивание беременности при преинвазивном и микроинвазивном раке шейки матки - право и выбор пациенток в условиях информированного согласия. Онкогинекология. 2014; 4: 21-7. [Korolenkova L.I. Wearing out during pregnancy preinvasive and microinvasive cervical cancer - and the right choice of patients under conditions of informed consent. Onkoginekologiya. 2014; 4: 21-7. (in Russian)]
- Ali A.A., Richardson D., Hill N. A retrospective study of cervical screening in women under 25 years (2005-2009). Arch. Gynecol. Obstet. 2013; 87(4): 765-9.
- Abulafia O., Pezzullo J.C., Sherer D.M. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol. Oncol. 2003; 90(1): 137-44.
- Киселев В.И., Муйжиек Е.Л. Молекулярные механизмы развития дисплазии шейки матки: новые знания - новые возможности. М.; 2011. 19с. [Kiselev V.I., Muyzhnek E.L. Molecular mechanisms of the development of cervical dysplasia, new knowledge - new opportunities. Moscow; 2011. 19 p. (in Russian)]
- Акуленко Л.В. Клиническая лекция: о наследственном раке органов женской репродуктивной системы. Онкогинекология. 2012; 1: 24-31. [Akulenko L.V. Clinical Lecture: a hereditary cancer of the female reproductive system. Onkoginekologiya. 2012; 1: 24-31. (in Russian)]
- Kreimer A.R. Clinical lectures. HPV and extra-cervical cancers. U.S. National Cancer Institute. Epidemiology, Prevention, and Control of Site-Specific Tumors; 2009. 23p.
Supplementary files
